neurons in the hippocampus and could contribute to schizo- Klotho acts to stimulate the Na*/K‘-ATPase responsible for
phrenia [47]. Vitamin D acts to maintain the expression of the maintaining the Na* gradient necessary for Ca* extrusion
Nrf2 antioxidant pathway [48]. There is a marked decline in by NCX1. Finally, NRF2 increases the expression of many anti-
the level of Nrf2 in the AD brain compared with age-matched oxidants that ensure that ROS levels are kept low, which will
controls [49]. Genetic ablation of the VDR results in prema- prevent the sensitization of the RYRs that are triggering the
ture ageing in mice suggesting that vitamin D can maintain sAHP and memory erasure.
normal physiological ageing [50]. Such a conclusion is strongly supported by the obser-
Some of the most convincing evidence that vitamin D vation that vitamin D can reverse the Ca?*-dependent
deficiency contributes to the ageing process has emerged processes responsible for the age-related decline in memory
from studies on the decline of memory in ageing rats. When [67]. What is more significant is that vitamin D can enhance
considering memory mechanisms, it is important to point hippocampal synaptic function, and more significantly, it
out that the ageing process does not affect long-term mem- could prevent the decline in cognition [68].
ories, but it induces a slow and progressive deterioration in The fact that vitamin D deficiency brings about a dysregu-
the formation and retention of new memories [51]. This initial lation of both the Ca** and redox signalling pathways during
age-related decline in working memory is very subtle and has ageing has raised an interesting possibility that it could also
been linked to small changes in both the Ca?* and redox sig- contribute to the initiation of age-related diseases [2].

nalling pathways [51-53]. An alteration in Ca?* signalling has
been linked to ageing in the brain [54—58]. The early loss of
memory is caused by a number of subtle changes such as an 5. The vitamin D/Klotho/Nrf2 regulatory network

elevation in the resting level of Ca?* [56] and an increase in

the expression of the Cay1.2 L-type Ca?* channel [58], which and disease
